MedTrace Logo

Newborn Screening for Spinal Muscular Atrophy

NCT02123186 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120267

Last updated 2016-11-02

No results posted yet for this study

Summary

To test if the routine newborn screening dried blood spots can be used to test if missing 2 copies of SMN1 gene, a status indicating spinal muscular atrophy

Conditions

Interventions

OTHER

newborn screening test for SMA

Routine newborn screening dried blood spots sample is used to test if missing 2 copies of SMN1 gene.

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Yin-Hsiu Chien, M.D., PhD. · National Taiwan University Hospital

Eligibility

Min Age
2 Days
Max Age
3 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02123186 on ClinicalTrials.gov